| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815227A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF |
| 01/07/1998 | EP0815224A1 Receptor activation by gas6 |
| 01/07/1998 | EP0815223A1 Dermatomyositis-specific auto-antigen |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815219A1 Human b-cell translocation genes-2 and 3 |
| 01/07/1998 | EP0815214A1 Dna molecules, preparation thereof and use thereof in gene therapy |
| 01/07/1998 | EP0815211A1 New defined enzyme mixtures for obtaining cells and treating wounds |
| 01/07/1998 | EP0815210A1 An enzyme with aminopeptidase activity |
| 01/07/1998 | EP0815209A1 Novel endoglucanases |
| 01/07/1998 | EP0815208A1 Amylase variants |
| 01/07/1998 | EP0815199A1 Human deoxycytidine kinase 2 |
| 01/07/1998 | EP0815193A1 An improved laundry detergent composition comprising amylase |
| 01/07/1998 | EP0815142A1 Antigen composition against mycoplasma |
| 01/07/1998 | EP0815140A1 Production in yeasts of stable antibody fragments |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815125A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 01/07/1998 | EP0815121A1 Modified-affinity streptavidin |
| 01/07/1998 | EP0815119A1 Multiple drug resistance gene of aspergillus flavus |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814663A1 Novel pesticidal composition and bacillus thuringiensis strain |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0690920B1 Biological control agents containing mollusc toxins |
| 01/07/1998 | EP0689625B1 Pitch degradation with white rot fungi |
| 01/07/1998 | EP0682529B1 Antibody for the treatment of insulin dependent diabetes |
| 01/07/1998 | EP0586372B1 RECOMBINANT 21 kD COCOA PROTEIN AND PRECURSOR |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0527758B1 Recombinant yeasts containing the dna sequences coding for xylose reductase and xylitol dehydrogenase enzymes |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | EP0463110B1 Monoclonal antibodies for metallic cations |
| 01/07/1998 | EP0447424B1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 01/07/1998 | EP0406357B1 Functional recombinantly prepared synthetic protein polymer |
| 01/07/1998 | EP0284603B1 Use of promoters of filamentous fungi |
| 01/07/1998 | CN1169752A Animal feed additives comprising xylanase |
| 01/07/1998 | CN1169734A Method for purifying keratinocyte growth factors |
| 01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
| 01/06/1998 | US5705617 Neurotrophic factors having altered receptor binding specificities |
| 01/06/1998 | US5705616 Proteins from yeast host strains with defects in N-glycosylation |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705387 Heat-inducible N-degron module |
| 01/06/1998 | US5705386 Derived from microorganisms ofgenus rhodococcus with specified size |
| 01/06/1998 | US5705383 Inoculating log with schizophyllum, trichaptum and/or phanerochaete fungi; conserves electricity |
| 01/06/1998 | US5705382 Immobilized cells in particles |
| 01/06/1998 | US5705377 Tyrosine kinase |
| 01/06/1998 | US5705370 Process for producing L-amino acids by fermentation |
| 01/06/1998 | US5705367 Neisseria having reading frames |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705358 Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from a aspergillus endoxylanase II gene |
| 01/06/1998 | US5705352 Multiple drug resistance gene of Aspergillus fumigatus |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705161 Immunogenic meningococcal LPS and other membrane vesicles and vaccine therefrom |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | CA2131284C Process for production of avermectins and cultures therefor |
| 01/06/1998 | CA2108897C Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
| 12/31/1997 | WO1997049826A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus |
| 12/31/1997 | WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997037032A3 Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
| 12/31/1997 | CN1169162A Process for fermentative prepn. of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low |
| 12/31/1997 | CN1169161A Attenuated viruses and method of making same |
| 12/31/1997 | CN1169160A Deoxyribonucleic acid coding for glutathion-S-transferase and its use |
| 12/31/1997 | CN1169159A Method of desulfurization of fossil fuel with flavoprotein |
| 12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
| 12/30/1997 | US5703209 Purified and isolated polypeptide encoded by nucleic acid sequence of nucleic acid molecule which is fragment of gene encoding amyloid precursor protein isoform |
| 12/30/1997 | US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5703039 Chimeric toxins |
| 12/30/1997 | US5702939 Glucosamine-6-phosphate deaminase and process for producing the same |
| 12/30/1997 | US5702936 Polypeptides |
| 12/30/1997 | US5702934 Processes for producing an enzyme |
| 12/30/1997 | US5702930 From corresponding nitrile compound |
| 12/30/1997 | US5702924 Process for preparing antiparasitic agents |
| 12/30/1997 | US5702923 Active against bacteria and effective at ph between 2 and 8 |
| 12/30/1997 | US5702921 Expression of biologically active human C-reactive protein in escherichia coli |
| 12/30/1997 | US5702920 Polypeptides |
| 12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
| 12/30/1997 | US5702907 Nucleotide sequence |
| 12/30/1997 | US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 12/30/1997 | US5702891 HAV probes for use in solution phase sandwich hybridization and assays for detecting the presence of HAV |
| 12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/30/1997 | CA2133850C Process for preparing virus-resistant transgenic plant |
| 12/29/1997 | EP0814164A2 A novel cDNA of direct-acting fibrinolytic serine protease |
| 12/29/1997 | EP0814162A2 Expression of the alpha-toxin gene (hla) of staphylococcus aureus using a chromosomally encoded hla-lacZ gene fusion |
| 12/29/1997 | EP0814160A2 KEX2 proteinase inhibitor |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |